48

EMIS Group PLCFRA EMIS Group Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

1.648

Small

Exchange

XFRA - Deutsche Boerse AG

483.F Stock Analysis

48

Uncovered

EMIS Group PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

99/100

Moderate score

Market cap $B

1.648

Dividend yield

Shares outstanding

62.963 B

EMIS Group Plc engages in the provision of healthcare software and services. The company operates through two segments: EMIS Health and EMIS Enterprise. EMIS Health segment is a supplier of integrated care technology to the National Health Service (NHS), including primary, community, acute and social care. Its EMIS Enterprise segment is focused on growth in the business-to-business (B2B) technology sector within the healthcare market, including management of medicines, partner businesses, life sciences and patient-facing services. The firm operates through its subsidiaries, which include Egton Medical Information Systems Limited, trading under the EMIS brand; Patient Platform Limited, carries on the business of Patient.info and Patient Access; and Pinnacle Systems Management Limited, is a provider of service management solutions to the community pharmacy market. Its clinical software business supplies essential technology to healthcare organization.

View Section: Eyestock Rating